Document is current

Article History

Received: 26 July 2024

Accepted: 27 November 2024

First Online: 26 December 2024

Declarations

:

: Prasad T. Oommen has received study support from Novartis. Tilmann Kallinich received research support from Novartis. Juergen Rech has received grants from Novartis and Sobi; speaker fees from BMS, Novartis and Sobi; support for attending meetings and travel from BMS; and has participated on a data safety monitoring board and/or advisory board for BMS, Novartis, Sobi. Norbert Blank has received grant/research support from Novartis and Sobi; is a consultant of Novartis, Sobi, Lilly, Pfizer, AbbVie, BMS, MSD, Actelion, UCB, Boehringer Ingelheim and Roche. Julia Weber-Arden was an employee of Novartis at the time of data acquisition and drafting of the manuscript and now is an employee of Fresenius Kabi at the time of publication. Jasmin B. Kuemmerle-Deschner has received grant/research support from Novartis and Sobi and is a consultant of Novartis and Sobi.

: The study was conducted according to the principles of the Declaration of Helsinki. The Ethics Committee of the Medical Faculty and the University Hospital Tübingen, as the leading ethics committee, and the local ethics committees of participating institutions, i.e., The Ethics Committee of Charité-Universitätsmedizin Berlin, The Ethics Committee of the Friedrich-Alexander University Erlangen-Nuremberg, The Heidelberg Ethics Committee and The Ethics Committee at the Faculty of Medicine of Heinrich Heine University Düsseldorf, Germany, approved the protocol used in this registry. Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of the research.